
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $13.3B | -- | -- | $0.35 | -- |
08/08/2025 | Q2 | $13B | -- | -- | $0.33 | -- |
05/09/2025 | Q1 | $13.3B | $12B | $0.49 | $0.45 | $0.04 |
02/07/2025 | Q4 | $13.8B | $12.4B | -$0.04 | $0.42 | -$0.46 |
11/08/2024 | Q3 | $13.1B | $12.7B | $0.22 | $0.31 | -$0.09 |
08/02/2024 | Q2 | $12.8B | $12.9B | $0.26 | $0.32 | -$0.06 |
05/03/2024 | Q1 | $13B | $12B | $0.29 | $0.39 | -$0.10 |
02/09/2024 | Q4 | $13.4B | $12.7B | $0.36 | $0.35 | $0.01 |
11/01/2023 | Q3 | -- | -- | $0.20 | $0.23 | -$0.03 |
08/02/2023 | Q2 | -- | -- | $0.32 | $0.20 | $0.12 |
05/05/2023 | Q1 | -- | -- | $0.52 | $0.36 | $0.16 |
02/08/2023 | Q4 | -- | -- | $0.30 | $0.35 | -$0.05 |
11/02/2022 | Q3 | -- | -- | $0.48 | $0.29 | $0.19 |
08/03/2022 | Q2 | -- | -- | $0.22 | $0.20 | $0.02 |
05/04/2022 | Q1 | -- | -- | $0.19 | $0.36 | -$0.17 |
02/09/2022 | Q4 | -- | -- | $0.56 | $0.27 | $0.29 |
11/02/2021 | Q3 | -- | -- | -$0.15 | $0.23 | -$0.38 |
08/03/2021 | Q2 | -- | -- | -$0.37 | $0.22 | -$0.59 |
05/04/2021 | Q1 | -- | -- | $0.51 | $0.25 | $0.26 |
02/09/2021 | Q4 | -- | -- | -$0.11 | $0.35 | -$0.46 |
11/02/2020 | Q3 | -- | -- | $0.13 | $0.33 | -$0.20 |
08/04/2020 | Q2 | -- | -- | $0.13 | $0.26 | -$0.13 |
05/05/2020 | Q1 | -- | -- | -$3.98 | $0.46 | -$4.44 |
02/04/2020 | Q4 | -- | -- | $0.35 | $0.49 | -$0.14 |
11/05/2019 | Q3 | -- | -- | $0.55 | $0.41 | $0.14 |
08/06/2019 | Q2 | -- | -- | $0.54 | $0.40 | $0.14 |
05/07/2019 | Q1 | -- | -- | $1.20 | $0.58 | $0.62 |
02/05/2019 | Q4 | -- | -- | $1.38 | -- | -- |
11/06/2018 | Q3 | -- | -- | $0.87 | -- | -- |
08/07/2018 | Q2 | -- | -- | $0.07 | -- | -- |
05/08/2018 | Q1 | -- | -- | $0.33 | -- | -- |
02/06/2018 | Q4 | -- | -- | $0.19 | -- | -- |
11/06/2017 | Q3 | -- | -- | -$0.01 | -- | -- |
08/08/2017 | Q2 | -- | -- | $0.21 | -- | -- |
05/08/2017 | Q1 | -- | -- | $0.58 | -- | -- |
02/07/2017 | Q4 | -- | -- | $0.14 | -- | -- |
11/03/2016 | Q3 | -- | -- | $0.40 | -- | -- |
08/02/2016 | Q2 | -- | -- | -$0.20 | -- | -- |
05/04/2016 | Q1 | -- | -- | $0.07 | -- | -- |
02/08/2016 | Q4 | -- | -- | $0.24 | -- | -- |
12/03/2015 | Q3 | -- | -- | $0.24 | -- | -- |
Plains All American Pipeline LP reported $12B worth of top line sales in its most recent quarter.
Plains All American Pipeline LP announced earnings per share of $0.49 which represents a beat of analyst forecast a $0.45 per share.
Plains All American Pipeline LP reported $620M that represents $0.88 per share over the last quarter.
Plains All American Pipeline LP's earnings are forecast to grow from $0.73 per share to $1.45 per share next year representing an increase of 117.6%.
Plains All American Pipeline LP's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.